Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - indapamide hemihydrate, quantity: 1.25 mg; perindopril erbumine, quantity: 4 mg - tablet - excipient ingredients: hydroxypropylbetadex; povidone; lactose monohydrate; magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica; silicon dioxide - treatment of hypertension. treatment should not be initiated with this combination.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - perindopril erbumine, quantity: 8 mg - tablet - excipient ingredients: silicon dioxide; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; polacrilin potassium; hydroxypropylbetadex - treatment of hypertension. treatment of heart failure. in such patients it is recommended that perindopril sandoz be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril have not been demonstrated for new york heart association category iv patients). patients with established coronary artery disease (see section 5.1 pharmacodynamic properties), who are stable on concomitant therapy and have no heart failure, to reduce the risk of nonfatal myocardial infarction or cardiac arrest.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - perindopril erbumine, quantity: 4 mg - tablet - excipient ingredients: colloidal anhydrous silica; magnesium stearate; silicon dioxide; polacrilin potassium; hydroxypropylbetadex; microcrystalline cellulose - treatment of hypertension. treatment of heart failure. in such patients it is recommended that perindopril sandoz be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril have not been demonstrated for new york heart association category iv patients). patients with established coronary artery disease (see section 5.1 pharmacodynamic properties), who are stable on concomitant therapy and have no heart failure, to reduce the risk of nonfatal myocardial infarction or cardiac arrest.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - perindopril erbumine, quantity: 2 mg - tablet - excipient ingredients: magnesium stearate; microcrystalline cellulose; polacrilin potassium; silicon dioxide; hydroxypropylbetadex; colloidal anhydrous silica - treatment of hypertension. treatment of heart failure. in such patients it is recommended that perindopril sandoz be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril have not been demonstrated for new york heart association category iv patients). patients with established coronary artery disease (see see section 5.1 pharmacodynamic properties), who are stable on concomitant therapy and have no heart failure, to reduce the risk of nonfatal myocardial infarction or cardiac arrest.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - drospirenone,ethinylestradiol -

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - aspirin, quantity: 100.008 mg - tablet, enteric coated - excipient ingredients: citric acid; macrogol 6000; hypromellose; stearic acid; carbomer 941; methacrylic acid copolymer; sodium hydroxide; pregelatinised maize starch; purified talc; betadex; microcrystalline cellulose; maize starch; purified water; sunset yellow fcf aluminium lake; titanium dioxide; xanthan gum; polyvinyl alcohol; lecithin - for the treatment of patients with known cardiovascular or cerebrovascular disease an antiplatelet agent for prophylaxis against acute myocardial infarction, unstable angina, transient ischaemic attack and cerebrovascular accident (stroke)

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - aspirin, quantity: 100.008 mg - tablet, enteric coated - excipient ingredients: sunset yellow fcf aluminium lake; titanium dioxide; sodium hydroxide; betadex; citric acid; microcrystalline cellulose; purified water; methacrylic acid copolymer; macrogol 6000; carbomer 941; maize starch; stearic acid; hypromellose; purified talc; pregelatinised maize starch; xanthan gum; polyvinyl alcohol; lecithin - for the treatment of patients with known cardiovascular or cerebrovascular disease as an antiplatelet agent for prophylaxis against acute myocardial infarction, unstable angina, transient ischaemic attack and cerebrovascular accident (stroke)

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

medreich australia pty ltd - aspirin, quantity: 100.008 mg - tablet, enteric coated - excipient ingredients: hypromellose; maize starch; sodium hydroxide; betadex; sunset yellow fcf aluminium lake; purified talc; macrogol 6000; purified water; methacrylic acid copolymer; microcrystalline cellulose; carbomer 941; citric acid; titanium dioxide; pregelatinised maize starch; stearic acid; xanthan gum; polyvinyl alcohol; lecithin - for the treatment of patients with known cardiovascular or cerebrovascular disease an antiplatelet agent for prophylaxis against acute myocardial infarction, unstable angina, transient ischaemic attack and cerebrovascular accident (stroke)

Örményország - angol - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

bayer weimar gmbh & co. kg - pink tablet-drospirenone, ethinyl estradiol, levomefolate (levomefolate calcium); light orange tablet-levomefolate (levomefolate calcium) - tablets film-coated - pink tablet-3mg+0,02mg+0,451mg

Örményország - angol - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

bayer weimar gmbh & co. kg - light pink tablet-drospirenone, ethinylestradiol, white tablet- inactive - tablets film-coated - 3mg+ 0,02mg